SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,835.78 776.01
( 1.02%)

Global Indices

Nasdaq

52,223.83 255.58
(0.49%)

Dow Jones

7,434.43 1.45
(0.02%)

Hang Seng

64,889.11 277.96
(0.43%)

Nikkei 225

10,802.25 66.02
(0.61%)

Forex

USD-INR

96.67 0.19
(0.20%)

EUR-INR

110.18 0.12
(0.10%)

GBP-INR

129.04 -0.01
(0.00%)

JPY-INR

0.59 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aarti Drugs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524348

INE767A01016

153.9158541

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AARTIDRUGS

22.17

3751.65

EPS(TTM)

Face Value()

Div & Yield %

18.54

0.49

Back

Indostar Capital Finance reports consolidated net loss of Rs 423.93 crore in the March 2026 quarter

May 27,2026

Net loss of Indostar Capital Finance reported to Rs 423.93 crore in the quarter ended March 2026 as against net profit of Rs 36.19 crore during the previous quarter ended March 2025. Sales declined 6.95% to Rs 346.67 crore in the quarter ended March 2026 as against Rs 372.56 crore during the previous quarter ended March 2025.

For the full year,net profit rose 16.54% to Rs 140.45 crore in the year ended March 2026 as against Rs 120.52 crore during the previous year ended March 2025. Sales declined 0.79% to Rs 1393.12 crore in the year ended March 2026 as against Rs 1404.17 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	346.67	372.56	-7	1393.12	1404.17	-1
OPM %	-82.46	56.67	-	-16.31	58.29	-
PBDT	-417.64	20.26	PL	-847.67	83.17	PL
PBT	-423.92	12.52	PL	-876.54	52.55	PL
NP	-423.93	36.19	PL	140.45	120.52	17

76,835.78 776.01 ( 1.02%)

52,223.83 255.58 (0.49%)

7,434.43 1.45 (0.02%)

64,889.11 277.96 (0.43%)

10,802.25 66.02 (0.61%)

96.67 0.19 (0.20%)

110.18 0.12 (0.10%)

129.04 -0.01 (0.00%)

0.59 0.00 (-0.04%)